Parallel changes in brain flunitrazepam binding and density of noradrenergic innervation.

Area of Science:

• Neuroscience
• Pharmacology
• Developmental Biology

Background:

• Neonatal administration of 6-hydroxydopa (6-OH-DOPA) and DSP 4 causes significant alterations in central noradrenergic neuron development.
• These neurotoxins lead to permanent denervation of the cerebral cortex and hyperinnervation of the brain stem and cerebellum.

Purpose of the Study:

• To investigate the relationship between noradrenergic innervation and benzodiazepine receptor binding in specific brain regions.
• To examine the effects of neonatal neurotoxin exposure on [3H]flunitrazepam binding sites.

Main Methods:

• Adult rats were treated neonatally with 6-OH-DOPA and/or DSP 4.
• Membranes were isolated from the cerebellum, brain stem, and cerebral cortex for [3H]flunitrazepam binding assays.
• Binding site density and affinity were analyzed.

Main Results:

• Both toxins increased [3H]flunitrazepam binding sites in the cerebellum and brain stem, with 6-OH-DOPA having a more pronounced effect in the brain stem.
• A reduction in binding sites was observed in the cerebral cortex following treatment with either neurotoxin.
• No significant changes in the affinity of binding sites were detected.
• Subsequent DSP 4 administration in 6-OH-DOPA treated rats normalized binding sites to levels seen in animals treated only with DSP 4.

Conclusions:

• The findings strongly support a parallel relationship between the density of brain noradrenergic innervation and benzodiazepine receptor density.
• Benzodiazepine receptor levels are significantly influenced by the developmental trajectory of noradrenergic pathways.